OXB.L
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. The company operates in two segments, Platform and Product. Its LentiVector platform technology integrates genes into non-dividing cells, including neurons in the brain and retinal cells in the eye, as well as accommodates various therapeutic genes. The company's products under development stage include Axo-Lenti-PD, a gene-based treatment for parkinson's disease; OXB-302, which is in pre-clinical stage for the treatment of haematological tumours; OXB-401 that is in pre-clinical stage for the treatment of liver indication;...[Read more]
Industry
Biotechnology
IPO Date
1996-12-13
Stock Exchange
LSE
Ticker
OXB.L
According to Oxford Biomedica plc’s latest financial reports and current stock price. The company's current Enterprise Value is 719.71M. This represents a change of 99.67% compared to the average of 360.46M of the last 4 quarters.
The mean historical Enterprise Value of Oxford Biomedica plc over the last ten years is 440.45M. The current 719.71M Enterprise Value has changed 16.24% with respect to the historical average. Over the past ten years (40 quarters), OXB.L's Enterprise Value was at its highest in in the June 2021 quarter at 1.02B. The Enterprise Value was at its lowest in in the June 2013 quarter at 16.16M.
Average
440.45M
Median
426.87M
Minimum
132.13M
Maximum
927.25M
Discovering the peaks and valleys of Oxford Biomedica plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 138.00%
Maximum Annual Enterprise Value = 927.25M
Minimum Annual Increase = -57.66%
Minimum Annual Enterprise Value = 132.13M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 482.64M | 119.22% |
| 2023 | 220.16M | -43.92% |
| 2022 | 392.62M | -57.66% |
| 2021 | 927.25M | 17.29% |
| 2020 | 790.53M | 71.44% |
| 2019 | 461.13M | -7.52% |
| 2018 | 498.59M | 58.56% |
| 2017 | 314.46M | 138.00% |
| 2016 | 132.13M | -28.57% |
| 2015 | 184.96M | 99.28% |
The current Enterprise Value of Oxford Biomedica plc (OXB.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
365.14M
5-year avg
562.64M
10-year avg
440.45M
Oxford Biomedica plc’s Enterprise Value is greater than Avacta Group Plc (345.70M), less than Craneware plc (866.70M), greater than PureTech Health plc (159.09M), greater than Faron Pharmaceuticals Oy (234.97M), less than Avon Technologies PLC (786.16M), less than Uniphar plc (1.29B), greater than 4basebio PLC (94.62M), greater than Scancell Holdings plc (102.11M), greater than SkinBioTherapeutics Plc (34.72M), greater than Allergy Therapeutics plc (494.46M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 345.70M | N/A | |
| 866.70M | N/A | |
| 159.09M | N/A | |
| 234.97M | N/A | |
| 786.16M | N/A | |
| 1.29B | N/A | |
| 94.62M | N/A | |
| 102.11M | N/A | |
| 34.72M | N/A | |
| 494.46M | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oxford Biomedica plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oxford Biomedica plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oxford Biomedica plc's Enterprise Value?
What is the highest Enterprise Value for Oxford Biomedica plc (OXB.L)?
What is the 3-year average Enterprise Value for Oxford Biomedica plc (OXB.L)?
What is the 5-year average Enterprise Value for Oxford Biomedica plc (OXB.L)?
How does the current Enterprise Value for Oxford Biomedica plc (OXB.L) compare to its historical average?